-
Article | 2020.07.27
Our mission
Our missionThe Institut Pasteur Technology Transfer and Industrial Partnership Department has generated close to 700 million euros in revenue over the last 15 years.The aim is to boost an open approach to future industry partners, from startups to major groups, to adapt more efficiently to the current and future requirements of society.The Technology Transfer and Industrial Partnership Department...
-
Document de presse | 2020.12.17
ComCor study on places of infection with SARS-CoV-2: where are French people catching the virus?
The Institut Pasteur, in partnership with the French National Health Insurance Fund (CNAM), Santé publique France and the Ipsos Social Research Institute, recently presented the results of the ComCor epidemiological study on circumstances and places of infection with the SARS-CoV-2 virus. The aim of the study was to identify the socio-demographic factors, places visited and behaviors associated...
-
Document de presse | 2021.03.09
ComCor: Study examining the sociodemographic, behavioral and practical factors associated with SARS-CoV-2 infection
The ComCor study is conducted by the Institut Pasteur in partnership with the French National Health Insurance Fund (CNAM), Ipsos and Santé publique France.Intermediate analysis, on March 1, 2021The ComCor study, which currently covers the period from October 1, 2020 to January 31, 2021, includes 77,208 participants with acute SARS-CoV-2 infection, excluding healthcare workers (8.2% of those...
-
Article | 2021.06.24
"HR Excellence in Research" Accreditation
In December 2021, the Institut Pasteur gained the HR Excellence in Research Award from the European Commission and has embarked on a process of continuous improvement regarding recruitment and working conditions for scientists, while strengthening its attractiveness at the international level.
-
News | 2021.09.02
Use of bacteriophages for preventing the most common foodborne infection, salmonellosis
Salmonellosis caused by the Salmonella bacterium is the most common example of foodborne infections, which remain a global public health problem, with over 600 million infections and 400,000 deaths every year. Use of antibiotics during outbreaks entails a risk of resistance. Scientists at the Institut Pasteur have demonstrated that bacteriophages may be used as a prophylactic treatment.The...
-
Article | 2021.10.18
Yersin Class (2014-2017)
Ph.D. StudentUndergraduate studiesLaboratoryThesis AdvisorLab HeadDoctoral SchoolPh.D. projectEugenia COVERNTONUniversidad Nacional de Rosario, ArgentinaStructural VirologyFrançois Bontems / Giovana Barba-SpaethFélix ReyMTCIStructure-function studies on yellow fever virusAnna FUNKThe London School of Hygiene and Tropical Medicine (LSHTM), UKEpidemiologyof Emerging ...
-
Article | 2022.02.03
Gender Equality Plan
As part of its commitment to gender equality in the workplace, the Institut Pasteur has adopted a Gender Equality Plan (GEP). The GEP is a new step aimed at strengthening the Institut Pasteur's policy for equality, diversity and inclusion.
-
News | 2023.10.06
Diphtheria: a novel bacterial species identified
A team from the Institut Pasteur has described a novel bacterial species in the Corynebacteriaceae family, capable of causing diphtheria. The identification of this distinct species will pave the way for improved surveillance and disease prevention.
-
Fiche maladie | 2015.10.06
Leprosy
Leprosy is a chronic bacterial condition and a neglected tropical disease. Although effective treatment exists, thousands of new cases are recorded every year. Leprosy remains a major public health issue for several countries in Africa, Asia and Latin America.
-
News | 2023.07.26
NK cells effective against pneumococcus
Natural killer (NK) cells are mainly studied for their ability to eliminate tumor cells or cells infected with viruses. Scientists have now demonstrated that these cells also have particular properties that enable them to defend the body from a deadly bacterium, making them a potential alternative to antibiotics.